87 related articles for article (PubMed ID: 24962340)
1. Oral dosing with multi-antigenic construct induces atheroprotective immune tolerance to individual peptides in mice.
Mundkur L; Ponnusamy T; Philip S; Rao LN; Biradar S; Deshpande V; Kumar R; Lu X; Kakkar VV
Int J Cardiol; 2014 Aug; 175(2):340-51. PubMed ID: 24962340
[TBL] [Abstract][Full Text] [Related]
2. Long-Term Efficacy and Safety of Immunomodulatory Therapy for Atherosclerosis.
Thota LN; Ponnusamy T; Lu X; Mundkur L
Cardiovasc Drugs Ther; 2019 Aug; 33(4):385-398. PubMed ID: 31332656
[TBL] [Abstract][Full Text] [Related]
3. Induction of oral tolerance to HSP60 or an HSP60-peptide activates T cell regulation and reduces atherosclerosis.
van Puijvelde GH; van Es T; van Wanrooij EJ; Habets KL; de Vos P; van der Zee R; van Eden W; van Berkel TJ; Kuiper J
Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2677-83. PubMed ID: 17901374
[TBL] [Abstract][Full Text] [Related]
4. Regulating Inflammatory Immune Response to Atherogenic Antigens Prevents Development and Progression of Atherosclerosis in New Zealand White Rabbits.
Philip S; Ponnusamy T; Rao LN; Biradar S; Kumar R; Deshpande V; Lu X; Kakkar VV; Mundkur LA
Can J Cardiol; 2016 Aug; 32(8):1008.e1-1008.e10. PubMed ID: 27062234
[TBL] [Abstract][Full Text] [Related]
5. Immune regulation by oral tolerance induces alternate activation of macrophages and reduces markers of plaque destabilization in Apob
Thota LN; Ponnusamy T; Philip S; Lu X; Mundkur L
Sci Rep; 2017 Jun; 7(1):3997. PubMed ID: 28638138
[TBL] [Abstract][Full Text] [Related]
6. Oral administration of recombinant Mycobacterium smegmatis expressing a tripeptide construct derived from endogenous and microbial antigens prevents atherosclerosis in ApoE(-/-) mice.
Deshpande V; Krishnan R; Philip S; Faludi I; Ponnusamy T; Thota LN; Endresz V; Lu X; Kakkar VV; Mundkur LA
Cardiovasc Ther; 2016 Oct; 34(5):314-24. PubMed ID: 27241889
[TBL] [Abstract][Full Text] [Related]
7. Mycobacterial heat shock protein 65 (mbHSP65)-induced atherosclerosis: Preventive oral tolerization and definition of atheroprotective and atherogenic mbHSP65 peptides.
Grundtman C; Jakic B; Buszko M; Onestingel E; Almanzar G; Demetz E; Dietrich H; Cappellano G; Wick G
Atherosclerosis; 2015 Sep; 242(1):303-10. PubMed ID: 26233917
[TBL] [Abstract][Full Text] [Related]
8. Mucosal tolerance to a combination of ApoB and HSP60 peptides controls plaque progression and stabilizes vulnerable plaque in Apob(tm2Sgy)Ldlr(tm1Her)/J mice.
Mundkur L; Mukhopadhyay R; Samson S; Varma M; Kale D; Chen D; Shivaprasad S; Sivanandan H; Soman V; Lu X; Kakkar VV
PLoS One; 2013; 8(3):e58364. PubMed ID: 23505495
[TBL] [Abstract][Full Text] [Related]
9. Intranasal immunization with an apolipoprotein B-100 fusion protein induces antigen-specific regulatory T cells and reduces atherosclerosis.
Klingenberg R; Lebens M; Hermansson A; Fredrikson GN; Strodthoff D; Rudling M; Ketelhuth DF; Gerdes N; Holmgren J; Nilsson J; Hansson GK
Arterioscler Thromb Vasc Biol; 2010 May; 30(5):946-52. PubMed ID: 20167655
[TBL] [Abstract][Full Text] [Related]
10. Impact of multiple antigenic epitopes from ApoB100, hHSP60 and Chlamydophila pneumoniae on atherosclerotic lesion development in Apob(tm2Sgy)Ldlr(tm1Her)J mice.
Lu X; Xia M; Endresz V; Faludi I; Szabo A; Gonczol E; Mundkur L; Chen D; Kakkar V
Atherosclerosis; 2012 Nov; 225(1):56-68. PubMed ID: 22959702
[TBL] [Abstract][Full Text] [Related]
11. Mapping of the lingual immune system reveals the presence of both regulatory and effector CD4+ T cells.
Mascarell L; Lombardi V; Zimmer A; Louise A; Tourdot S; Van Overtvelt L; Moingeon P
Clin Exp Allergy; 2009 Dec; 39(12):1910-9. PubMed ID: 19694757
[TBL] [Abstract][Full Text] [Related]
12. Establishment of nasal tolerance to heat shock protein-60 alleviates atherosclerosis by inducing TGF-β-dependent regulatory T cells.
Li H; Ding Y; Yi G; Zeng Q; Yang W
J Huazhong Univ Sci Technolog Med Sci; 2012 Feb; 32(1):24-30. PubMed ID: 22282240
[TBL] [Abstract][Full Text] [Related]
13. Effects of oral and subcutaneous administration of HSP60 on myeloid-derived suppressor cells and atherosclerosis in ApoE-/- mice.
Hu Y; Chen Z; Jiang L; Chen F; Jin R; Cheng L
Biochem Biophys Res Commun; 2018 Apr; 498(4):701-706. PubMed ID: 29107690
[TBL] [Abstract][Full Text] [Related]
14. Porphyromonas gingivalis HSP60 peptides have distinct roles in the development of atherosclerosis.
Jeong E; Kim K; Kim JH; Cha GS; Kim SJ; Kang HS; Choi J
Mol Immunol; 2015 Feb; 63(2):489-96. PubMed ID: 25457882
[TBL] [Abstract][Full Text] [Related]
15. Induction of oral tolerance to oxidized low-density lipoprotein ameliorates atherosclerosis.
van Puijvelde GH; Hauer AD; de Vos P; van den Heuvel R; van Herwijnen MJ; van der Zee R; van Eden W; van Berkel TJ; Kuiper J
Circulation; 2006 Oct; 114(18):1968-76. PubMed ID: 17060383
[TBL] [Abstract][Full Text] [Related]
16. Immunization with a combination of ApoB and HSP60 epitopes significantly reduces early atherosclerotic lesion in Apobtm2SgyLdlrtm1Her/J mice.
Lu X; Chen D; Endresz V; Xia M; Faludi I; Burian K; Szabo A; Csanadi A; Miczak A; Gonczol E; Kakkar V
Atherosclerosis; 2010 Oct; 212(2):472-80. PubMed ID: 20609438
[TBL] [Abstract][Full Text] [Related]
17. Oral treatment with β-lactoglobulin peptides prevents clinical symptoms in a mouse model for cow's milk allergy.
Meulenbroek LA; van Esch BC; Hofman GA; den Hartog Jager CF; Nauta AJ; Willemsen LE; Bruijnzeel-Koomen CA; Garssen J; van Hoffen E; Knippels LM
Pediatr Allergy Immunol; 2013 Nov; 24(7):656-64. PubMed ID: 24028387
[TBL] [Abstract][Full Text] [Related]
18. Oral Tolerization with Mycobacterial Heat Shock Protein 65 Reduces Chronic Experimental Atherosclerosis in Aged Mice.
Wick C; Onestingel E; Demetz E; Dietrich H; Wick G
Gerontology; 2018; 64(1):36-48. PubMed ID: 28910785
[TBL] [Abstract][Full Text] [Related]
19. Oral anti-CD3 antibody treatment induces regulatory T cells and inhibits the development of atherosclerosis in mice.
Sasaki N; Yamashita T; Takeda M; Shinohara M; Nakajima K; Tawa H; Usui T; Hirata K
Circulation; 2009 Nov; 120(20):1996-2005. PubMed ID: 19884470
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of adjuvant-induced arthritis by interleukin-10-driven regulatory cells induced via nasal administration of a peptide analog of an arthritis-related heat-shock protein 60 T cell epitope.
Prakken BJ; Roord S; van Kooten PJ; Wagenaar JP; van Eden W; Albani S; Wauben MH
Arthritis Rheum; 2002 Jul; 46(7):1937-46. PubMed ID: 12124879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
